U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07456488) titled 'The Effect of 0.01% Atropine Eye Drops on Axial Length and Refraction in Myopic Children Compared to a Control Group' on Feb. 26.
Brief Summary: In this study, atropine 0.01% eye drops will be given to myopic children once at night daily for 6 months as compared to a control group to see the effect on axial length and refraction
Study Start Date: July 13, 2025
Study Type: INTERVENTIONAL
Condition:
Focus on Axial Length
Intervention:
DRUG: Atropine 0.01% eye drops
Eye drops atropine 0.01% given once nightly to group A for 6 months
Recruitment Status: RECRUITING
Sponsor: Liaquat National Hospital & Medical College
Informatio...